EP
MIRM icon

Elkfork Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Elkfork Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$4K Buy
+374
New +$4.59K ﹤0.01% 1053

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Elkfork Partners's MIRM Position: Q3 2019 in Review

Elkfork Partners opened a new position in Mirum Pharmaceuticals (MIRM) in Q3 2019: 374 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #1053 among its holdings.

39 funds tracked by Wall St. Rank hold MIRM as of Q3 2019.

  • Elkfork Partners held 374 shares of Mirum Pharmaceuticals worth $4K as of Q3 2019.
  • Mirum Pharmaceuticals was a new Elkfork Partners position in Q3 2019.
  • Mirum Pharmaceuticals made up ﹤0.01% of Elkfork Partners's portfolio in Q3 2019, its #1053 holding.
  • 39 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.